Sun Pharma
-
{
- All
- News
- Videos
-
Sun Pharma To Commercialise Novel Bad Cholesterol Drug Lerodalcibep In Ex-US, China Markets
Sun Pharma will commercialise and manufacture lerodalcibep in global markets outside the US and China after securing exclusive rights from LIB Therapeutics.
-
India's Sun Pharma, 8 Drugmakers Sign Pricing Deals With Team Trump
The deal comes amid Team Trump's pressure on midsize companies to fall in line with its pricing regime, as it expands its most-favoured-nation (MFN) pricing push.
-
Delhi HC Cracks Down On Alleged Fake Sun Pharma Products On Meesho
Sun Pharma shared a number of URLs of the alleged counterfeit products using their brand being sold on Meesho's platform.
-
Can Contaminated Eye Drops Cause Lasting Damage? Doctor Explains Risks
A recent eye drop recall has raised fresh concerns about contaminated ophthalmic medicines. Can they permanently damage your eyesight?
-
Sun Pharma Recalls Eye Drops In India After Contamination Scare
Sun Pharma has recalled multiple eye drop products in India due to contamination concerns and halted their distribution as a precaution.
-
Contamination Scare: Sun Pharma Recalls 10 Eye Drop Brands As Experts Warn Of Health Risks
Sun Pharma has recalled multiple eye drop brands in India over contamination concerns. The move has increased focus on pharmaceutical safety standards, with experts warning that unsafe eye drops can cause infections and potential vision damage.
-
Sun Pharma Wins Legal Battle Over Pantocid's Name; Uses And Side Effects Of Proton Pump Inhibitors Explained
Pantocid Tablet belongs to a class of medicines known as proton pump inhibitors (PPIs). It is primarily used to reduce the amount of acid produced in your stomach.
-
Sun Pharma Wins Legal Battle Over Pantocid's Name; Uses And Side Effects Of Proton Pump Inhibitors Explained
Pantocid Tablet belongs to a class of medicines known as proton pump inhibitors (PPIs). It is primarily used to reduce the amount of acid produced in your stomach.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Obesity Treatment Drugs To Be New Growth Engine For Pharma Industry: Sun Pharma
Glucagon-like peptide-1 (GLP-1) receptor agonists are drugs that treat type 2 diabetes, high blood sugar, and obesity by regulating insulin production.
-
Buy, Sell Or Hold: Hawkins, Sun Pharma, PCBL, Sagility India, IDBI Bank — Ask Profit
Khush Bora, Founder of Khushbora.com and Lancelot DCunha, CIO of ValueX Wealth Connect LLP, provided insights on these investor queries and more on NDTV Profit's Ask Profit show.
-
Sun Pharma Q2 Review: Brokerages Largely Bullish On Portfolio Growth, Healthy Margins
Citi said Sun’s healthy margins should ease investor concerns, while Morgan Stanley highlighted that Sun maintained leadership in India.
-
Stock Picks Today: Sun Pharma, KPIT Tech, BHEL, Nazara Tech, CMS Info, Godrej Properties On Brokerages' Radar
Sun Pharma Ltd., KPIT Technologies Ltd., BHEL Ltd., Nazara Technologies Ltd., CMS Info Systems Ltd., and Godrej Properties Ltd., are among the companies garnering brokerage commentary today.
-
Sun Pharma Leads Pharma Stocks Decline After Trump Hikes Tariff To 100%
Other Pharmaceutical stocks seeing decline are Cipla Ltd., Dr Reddys Laboratories Ltd., Lupin Ltd. and Biocon Ltd.
-
Sun Pharma To Commercialise Novel Bad Cholesterol Drug Lerodalcibep In Ex-US, China Markets
Sun Pharma will commercialise and manufacture lerodalcibep in global markets outside the US and China after securing exclusive rights from LIB Therapeutics.
-
India's Sun Pharma, 8 Drugmakers Sign Pricing Deals With Team Trump
The deal comes amid Team Trump's pressure on midsize companies to fall in line with its pricing regime, as it expands its most-favoured-nation (MFN) pricing push.
-
Delhi HC Cracks Down On Alleged Fake Sun Pharma Products On Meesho
Sun Pharma shared a number of URLs of the alleged counterfeit products using their brand being sold on Meesho's platform.
-
Can Contaminated Eye Drops Cause Lasting Damage? Doctor Explains Risks
A recent eye drop recall has raised fresh concerns about contaminated ophthalmic medicines. Can they permanently damage your eyesight?
-
Sun Pharma Recalls Eye Drops In India After Contamination Scare
Sun Pharma has recalled multiple eye drop products in India due to contamination concerns and halted their distribution as a precaution.
-
Contamination Scare: Sun Pharma Recalls 10 Eye Drop Brands As Experts Warn Of Health Risks
Sun Pharma has recalled multiple eye drop brands in India over contamination concerns. The move has increased focus on pharmaceutical safety standards, with experts warning that unsafe eye drops can cause infections and potential vision damage.
-
Sun Pharma Wins Legal Battle Over Pantocid's Name; Uses And Side Effects Of Proton Pump Inhibitors Explained
Pantocid Tablet belongs to a class of medicines known as proton pump inhibitors (PPIs). It is primarily used to reduce the amount of acid produced in your stomach.
-
Sun Pharma Wins Legal Battle Over Pantocid's Name; Uses And Side Effects Of Proton Pump Inhibitors Explained
Pantocid Tablet belongs to a class of medicines known as proton pump inhibitors (PPIs). It is primarily used to reduce the amount of acid produced in your stomach.
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
Obesity Treatment Drugs To Be New Growth Engine For Pharma Industry: Sun Pharma
Glucagon-like peptide-1 (GLP-1) receptor agonists are drugs that treat type 2 diabetes, high blood sugar, and obesity by regulating insulin production.
-
Buy, Sell Or Hold: Hawkins, Sun Pharma, PCBL, Sagility India, IDBI Bank — Ask Profit
Khush Bora, Founder of Khushbora.com and Lancelot DCunha, CIO of ValueX Wealth Connect LLP, provided insights on these investor queries and more on NDTV Profit's Ask Profit show.
-
Sun Pharma Q2 Review: Brokerages Largely Bullish On Portfolio Growth, Healthy Margins
Citi said Sun’s healthy margins should ease investor concerns, while Morgan Stanley highlighted that Sun maintained leadership in India.
-
Stock Picks Today: Sun Pharma, KPIT Tech, BHEL, Nazara Tech, CMS Info, Godrej Properties On Brokerages' Radar
Sun Pharma Ltd., KPIT Technologies Ltd., BHEL Ltd., Nazara Technologies Ltd., CMS Info Systems Ltd., and Godrej Properties Ltd., are among the companies garnering brokerage commentary today.
-
Sun Pharma Leads Pharma Stocks Decline After Trump Hikes Tariff To 100%
Other Pharmaceutical stocks seeing decline are Cipla Ltd., Dr Reddys Laboratories Ltd., Lupin Ltd. and Biocon Ltd.
